This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,287.68, is for the delivery of 4,567,956,474 units of the prescription medication lisdexamfetamine 40 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of lisdexamfetamine 10 mg capsules, a prescription medication. The contract has a ceiling value of $1,057.51 and runs through March 3, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,539.16, is for the delivery of 4,567,420,917 units of the prescription drug lisdexamfetamine 40 mg capsules. The contract has a period of performance through March 3, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 50 mg capsules, a prescription medication, with a ceiling value of $2,230.72 and a period of performance ending on April 30, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,033,529 units of the prescription medication lisdexamfetamine 30 mg capsules. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $1,976.17 and a performance period through April 28, 2025. Amerisourcebergen Drug Corp also holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,704.52, is for the supply of lisdexamfetamine 30 mg capsules in 100-count bottles. The contract is a firm-fixed-price delivery order with an ultimate completion date of January 28, 2025. This contract award is not associated with a set-aside program and is part of a larger Indefinite...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,361.53, is for the delivery of Lisdexamfetamine 30 mg capsules in 100-count bottles. The contract is a Firm Fixed Price agreement and has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lisdexamfetamine 40 mg capsules, a medication used to treat certain mental health conditions. The contract has a ceiling value of $1,144.84 and a period of performance through March 4, 2025. This appears to be a firm fixed-price delivery order contract, with no set-aside designation,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,174.66, is for the delivery of lisdexamfetamine 40 mg capsules in 100-count bottles. The contract is a firm fixed-price delivery order with a completion date of January 31, 2025. This award does not have a set-aside designation, indicating it was open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,455.96, is for the delivery of 4,568,086,095 units of Lisdexamfetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...